New book by Larry Connors Click here Improve your trading - See how
Resolutions for the election of all the members of the Board of Directors, the selection of KMJ Corbin & Company as the Company's auditor, approval of an increase to the number of common shares authorized and the ability of the Board of Directors to initiate a possible reverse split of the Company's outstanding common stock all passed. The proposal to authorize the creation of 25,000,000 shares of preferred stock did not pass because it did not obtain the affirmative vote of the majority of the Company's outstanding shares of common stock.
Larry Stambaugh, CEO of CryoPort, stated, "I'm very pleased that our shareholders have supported management's recommendation on the resolutions. Having the flexibility to manage the capital structure of the Company will be important as we initiate the process of seeking to move from the OTC Bulletin Board to The NASDAQ Stock Market. Also, in connection with the recent filing of our Registration Statement on Form S-1 directed at raising $10 million of new capital, it is important for us to have these measures passed and in place to allow us to execute our commercialization strategies for the CryoPort Express(R)."
About CryoPort, Inc.
CryoPort (www.cryoport.com) is commercializing proprietary, technology-driven shipping products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed by CryoPort are essential components of the infrastructure required for the clinical testing, research and end user deliver of temperature-sensitive medicines and biomaterials in an increasingly complex logistical environment.
SAFE HARBOR STATEMENT
This press release contains forward-looking statements which are not purely historical, including statements regarding CryoPort's intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future. The forward-looking statements involve risks and uncertainties including, but not limited to, the risk that the company's NASDAQ listing application will not be approved, the risk that the company will not be able to raise sufficient additional capital to fully commercialize its CryoPort Express(R) and the risk that such commercialization will experience delays. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing product development; obtaining additional financing to support the company's operations and commercial launch of its products; and complying with government regulations. The company's business could be affected by a number of other factors, including the risk factors listed in the company's Registration Statement on Form S-1 filed with the SEC on October 6, 2009. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. CryoPort, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.
Contact: Stuart Fine Carpe DM, Inc. 908-469-1788
SOURCE: CryoPort
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
